Premium Healthcare Group
EEGX:PHGC0.08
EGP
0.00
(0.00%)
ISIN
EGS72XL1C014
Return %
Stock
S&P 500
1Y
8.00
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Cairo Egypt
- Similar Companies
- Business
- Premium Healthcare Group is an Egypt-based healthcare investment and diagnostic services provider that operates a diversified network of medical laboratories, specialized clinics, and healthcare management facilities across the Middle East and North Africa. Founded in 2014 and headquartered in Cairo, Egypt, the company delivers comprehensive clinical diagnostics, pathology testing, and healthcare operational solutions to individual patients, corporate clients, medical practitioners, and institutional healthcare facilities. The group operates through multiple specialized medical and diagnostic subsidiaries, offering services that include routine clinical pathology encompassing clinical chemistry, hematology, urinalysis, and immunology; advanced molecular diagnostics and genetic testing including polymerase chain reaction (PCR) assays and genetic profiling; histopathology, cytology, and oncological diagnostic screenings; microbiology, virology, and infectious disease testing; specialized hormonal assays and reproductive endocrinology diagnostics; healthcare logistics and supply chain management for third-party medical facilities; and outpatient clinical consultations across multi-specialty polyclinics. Premium Healthcare Group markets its diagnostic and clinical services under several established brands, including City Labs, Ezz Laboratories (Ezzlab), Hassab Labs, Cairo Clinical Labs, Premium Diagnostics, El Eyada Company, and Khadamat for Hospital Management. The company operates primarily in Egypt, with expanding international operations and regional partnerships in Saudi Arabia, the United Arab Emirates, and Jordan. In recent strategic developments, the company rebranded from City Lab to Premium Healthcare Group in September 2024 to reflect its transformation into an integrated healthcare platform. Concurrently, the group completed a large-scale corporate consolidation through the acquisition of ten healthcare and diagnostic entities, including Hassab Labs, Cairo Clinical Labs, and Ezz Laboratories, while executing a major capital increase from EGP 81.48 million to EGP 2.36 billion via debt-to-equity conversions and rights issues. Following this operational expansion and balance sheet restructuring, the company transitioned its equity listing from the Egyptian Exchange's SME market (Nilex) to the Main Market of the Egyptian Exchange under the ticker symbol PHGC.